HeartSciences (HSCS) Revenue & Revenue Breakdown
HeartSciences Revenue Highlights
Latest Revenue (Y)
$18.60K
Latest Revenue (Q)
$1.90M
HeartSciences Revenue by Period
HeartSciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-04-30 | $18.60K | 261.17% |
| 2023-04-30 | $5.15K | -64.17% |
| 2022-04-30 | $14.37K | -43.86% |
| 2021-04-30 | $25.60K | -60.11% |
| 2020-04-30 | $64.18K | - |
HeartSciences generated $18.60K in revenue during NA 2024, up 261.17% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
HeartSciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-07-31 | $1.90M | 43578.16% |
| 2025-04-30 | $4.35K | 100.00% |
| 2025-01-31 | - | 100.00% |
| 2024-10-31 | - | 100.00% |
| 2024-07-31 | - | 100.00% |
| 2024-04-30 | - | -100.00% |
| 2024-01-31 | $14.70K | 276.92% |
| 2023-10-31 | $3.90K | 100.00% |
| 2023-07-31 | - | -100.00% |
| 2023-04-30 | $5.14M | 263738.46% |
| 2023-01-31 | $1.95K | 100.00% |
| 2022-10-31 | - | -100.00% |
| 2022-07-31 | $3.20K | -22.87% |
| 2022-04-30 | $4.15K | 51.42% |
| 2022-01-31 | $2.74K | 100.00% |
| 2021-10-31 | - | -100.00% |
| 2021-07-31 | $7.48K | -49.94% |
| 2021-04-30 | $14.95K | - |
HeartSciences generated $1.90M in revenue during Q1 2026, up 43578.16% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
HeartSciences Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| PAVM | PAVmed | $3.00B | $979.00M |
| DHAI | DIH US | $62.86M | $19.81M |
| BFRI | Biofrontera | $37.30M | $8.59M |
| SSKN | STRATA Skin Sciences | $33.56M | $8.44M |
| BMRA | Biomerica | $5.42M | $1.38M |
| HSCS | HeartSciences | $18.60K | $1.90M |
| CDIO | Cardio Diagnostics | $2.02K | $940.00 |
| AMIX | Autonomix Medical | - | - |
| ADIL | Adial Pharmaceuticals | - | - |
| NRSN | NeuroSense Therapeutics | - | - |